Keyword: Ebola

Markets & Companies

Vaccine Research – an Ambitious and Important Venture

20.04.2020 - The worldwide spread of the corona virus shows once again that despite all technological progress, humanity is still exposed to health risks. The biotech and pharmaceutical...

Logistics & Supply Chain

Pharmaceutical Logistics: The African Journey

03.04.2017 - Africa is one of the most promising pharmerging markets. For a recent project, pharma supply-chain experts from Camelot Management Consultants visited more than a dozen countries...

News

Ebola Vaccine Trials Prove Efficacy

03.01.2017 - An experimental Ebola vaccine initially developed by the Public Health Agency of Canada and the US Army and eventually licensed to Merck, Sharp and Dohme, the international arm of...

News

China Sends Experimental Ebola Drug to Africa

20.10.2014 - A Chinese drugmaker with military ties has sent an experimental Ebola drug to Africa for use by Chinese aid workers and is planning clinical trials there to combat the disease...

News

Russian Scientists Said Working on Three Ebola Vaccines

15.10.2014 - Russian scientists are working on three potential Ebola vaccines and plan to introduce them within the next six months, health minister Veronika Skvortsova said, adding that one of...

News

US Steps up Production of Experimental Ebola Drug

06.10.2014 - The US government is stepping up production of ZMapp, believed to be one the most promising of the Ebola drugs currently under development. The Department of Health and Human...

News

GSK’s Ebola Vaccine Fast-tracked Into Clinical Trials

29.08.2014 - An experimental Ebola vaccine from GlaxoSmithKline is being fast-tracked into clinical trials with human patients, and the company plans to immediately begin building a stockpile...

News

Ebola Patients Reported Treated with Biotech Firm’s Drug

05.08.2014 - Shares of Tekmira Pharmaceuticals, one of a few companies to have developed Ebola treatments advanced enough to be tested on people, soared in early August 4 trading, but later...